Ratania para hemostático
Krameria lappacea — 3 estudios científicos revisados
Monografía ema para inflamación orofaríngea¿Sirve Ratania para hemostático?
La investigación científica ha explorado el potencial de Ratania (Krameria lappacea) en relación con hemostático. Se han identificado 3 estudios relevantes que examinan esta relación.
Compuestos activos involucrados: {'name': 'Proantocianidinas', 'class': 'Taninos condensados'}, {'name': 'Neolignanos', 'class': 'Fenilpropanoide'}, {'name': 'Ácido krámeriaico', 'class': 'Neolignano'}, Catequina, Epicatequina, Flavonoides, Kaempferol, Lignanos, Quercetina, Taninos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Ratania y hemostático:
INTRODUCTION: Recently, the use of botanicals as an alternative to coccidiostats has been an appealing approach for controlling coccidiosis. Therefore, this study was conducted to evaluate the potential role of aqueous methanolic extract (200 mg/kg) of METHODS: A total of 25 male C57BL/6 mice were divided into five groups (I, II, III, IV, and V). On 1 RESULTS: Treatment with extract and coccidiostat was continued for five consecutive days. While not reaching the efficacy level of the reference drug (amprolium), KLRE exhibited notable anticoccidial activity as assessed by key criteria, includi
PubMed: 38751432Anticoccidial and jejunum-protective effects of Krameria lappacea roots extract on experimental Eimeria papillata infection.
Coccidiosis is a protozoan parasitic disease caused by Eimeria species and affects wild and domestic animals. Coccidiostats are currently available to control this disease, although drug resistance has been confirmed for all of them. As a result, there is an urgent need to identify eco-friendly agents to control and treat this disease. This study aimed to investigate the ameliorative role of the Krameria lappacea roots extract (KLRE) on the outcome of coccidiosis induced by Eimeria papillata. Male C57BL/6 mice were divided into seven groups (5 mice/group), as follows: Group 1: noninfected-nont
PubMed: 38407507Bioguided identification of triterpenoids and neolignans as bioactive compounds from anti-infectious medicinal plants of the Taira Atacama's community (Calama, Chile).
ETHNOPHARMACOLOGICAL RELEVANCE: Previous ethnobotanical surveys from the north Andean part of Chile, where different ethnic groups are co-existing, with the preeminence of Aymara and Atacama traditions, revealed an extensive domestic use of the local flora. In these communities, traditional medicinal uses are mainly related to the treatment of respiratory, gastro-intestinal and urinary disorders, pain and inflammation, which is closely linked to epidemiological observations. AIM OF THE STUDY: As these symptoms may be related to infectious diseases, a bioguided evaluation of antibacterial and a
PubMed: 30412750Seguridad y Precauciones
La raíz de ratania tiene un perfil de seguridad favorable para uso tópico bucodental, respaldado por la monografía de la EMA y por siglos de uso tradicional. Para uso como enjuague bucal o dentífrico, no se reportan efectos adversos significativos a las concentraciones recomendadas. En casos raros, pueden ocurrir reacciones de hipersensibilidad en personas alérgicas a componentes de la planta. El uso prolongado de enjuagues muy concentrados podría causar sequedad y descamación de la mucosa oral por el efecto astringente excesivo. Para uso interno (decocción contra diarrea), se recomienda no superar 2 tazas diarias de infusión preparada con 5-10 gramos de raíz seca por litro de agua. El consumo excesivo puede provocar estreñimiento reactivo, náuseas y reducción de la absorción de hierro dietético.
Perfil completo: Ver todos los usos y evidencia de Ratania →